Literature DB >> 2360520

Doppler echocardiographic evaluation of left ventricular diastolic function in patients with systemic lupus erythematosus.

W H Leung1, K L Wong, C P Lau, C K Wong, C H Cheng, Y T Tai.   

Abstract

Subclinical myocardial involvement frequently occurs in patients with systemic lupus erythematosus (SLE). In this study, left ventricular diastolic function was assessed in 58 patients (54 female and 4 male; mean age 32 +/- 11 years) and in 40 sex-matched and age-matched healthy control subjects (37 female and 3 male; mean age 33 +/- 9 years) by means of pulsed Doppler echocardiography. All subjects had no clinical evidence of overt myocardial disease or abnormal left ventricular systolic function. Compared with the control group, patients with SLE had significantly prolonged isovolumic relaxation time (62 +/- 12 vs 80 +/- 14 msec; p less than 0.01), reduced peak early diastolic flow velocity (peak E) (82 +/- 18 vs 76 +/- 16 cm/sec; p less than 0.05), increased peak late diastolic flow velocity (peak A) (45 +/- 7 vs 53 +/- 8 cm/sec; p less than 0.01), reduced E/A ratio (1.81 +/- 0.32 vs 1.46 +/- 0.29; p less than 0.001), and lower deceleration rate of early diastolic flow velocity (EF slope) (489 +/- 151 vs 361 +/- 185 cm/sec2; p less than 0.05).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1990        PMID: 2360520     DOI: 10.1016/0002-8703(90)90163-r

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  9 in total

1.  [Cardiovascular monitoring of patients with systemic lupus erythematosus].

Authors:  H Schotte; H Becker; W Domschke; M Gaubitz
Journal:  Z Rheumatol       Date:  2005-11       Impact factor: 1.372

2.  Evaluation of cardiac function by two-dimensional speckle tracking echocardiography in ulcerative colitis patients.

Authors:  Altug Cincin; Murat Sunbul; Tarık Kivrak; Halil Atas; Ibrahim Sari; Kursat Tigen; Tarik Kani; Hakan Akin; Nese Imeryuz; Yelda Basaran
Journal:  Dig Dis Sci       Date:  2014-07-15       Impact factor: 3.199

3.  Right ventricular diastolic dysfunction in patients with anticardiolipin antibodies and antiphospholipid syndrome.

Authors:  M G Tektonidou; J P Ioannidis; I Moyssakis; K A Boki; V Vassiliou; P G Vlachoyiannopoulos; M K Kyriakidis; H M Moutsopoulos
Journal:  Ann Rheum Dis       Date:  2001-01       Impact factor: 19.103

4.  Cardiovascular Complications of Collagen Vascular Disease.

Authors:  Gary E. Sander; Thomas D. Giles
Journal:  Curr Treat Options Cardiovasc Med       Date:  2002-04

5.  Endothelial function is associated with myocardial diastolic function in women with systemic lupus erythematosus.

Authors:  Calvin W L Chin; Chee-Yang Chin; Marie X R Ng; Thu-Thao Le; Fei-Qiong Huang; Kok-Yong Fong; Julian Thumboo; Ru-San Tan
Journal:  Rheumatol Int       Date:  2014-02-19       Impact factor: 2.631

6.  M mode and Doppler echocardiographic assessment of left ventricular diastolic function in primary antiphospholipid syndrome.

Authors:  N Coudray; D de Zuttere; O Blétry; J C Piette; B Wechsler; P Godeau; J C Pourny; Y Lecarpentier; D Chemla
Journal:  Br Heart J       Date:  1995-11

7.  Assessment of inhomogeneities of repolarization in patients with systemic lupus erythematosus.

Authors:  Ahmet Avci; Kenan Demir; Bulent Behlul Altunkeser; Sema Yilmaz; Ahmet Yilmaz; Ahmet Ersecgin; Tarik Demir
Journal:  Ann Noninvasive Electrocardiol       Date:  2014-03-05       Impact factor: 1.468

8.  Diastolic function in children and adolescents on dialysis and after kidney transplantation: an echocardiographic assessment.

Authors:  A Goren; J Glaser; A Drukker
Journal:  Pediatr Nephrol       Date:  1993-12       Impact factor: 3.714

9.  Effects of chronic inflammatory bowel diseases on left ventricular structure and function: a study protocol.

Authors:  Ugo Cioffi; Michele M Ciulla; Matilde De Simone; Roberta Paliotti; Alberto Pierini; Fabio Magrini; Fiorenzo Botti; Ettore Contessini-Avesani
Journal:  BMC Public Health       Date:  2002-09-10       Impact factor: 3.295

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.